76
Participants
Start Date
November 30, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
tanezumab
Drug solution given intravenously only once at dose of 10 mg
tanezumab
Drug solution given subcutaneously only once at dose of 5 mg.
tanezumab
Drug solution given subcutaneously only once at dose of 10 mg.
tanezumab
Drug solution given subcutaneously only once at dose of 19 mg.
Pfizer Investigational Site, Cypress
Lead Sponsor
Pfizer
INDUSTRY